What are the side effects of trypsin-chymotrypsin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Trypsin-Chymotrypsin

Trypsin-chymotrypsin is generally well-tolerated with mild gastrointestinal side effects being most common, though occupational exposure can cause respiratory hypersensitivity reactions. 1, 2

Common Side Effects

The most frequently reported adverse effects are gastrointestinal in nature and typically mild:

  • Nausea - commonly reported but usually transient 1
  • Drowsiness - may occur during treatment 1
  • Constipation - reported as a temporary symptom 1

These symptoms are generally self-limiting and do not require discontinuation of therapy. 1

Occupational Hypersensitivity (Inhalational Exposure)

For individuals with occupational exposure to enzyme dusts, more serious reactions can occur:

  • Immediate airway hypersensitivity - well-documented with enzyme dust exposure 2
  • Specific IgE-mediated reactions - positive skin prick tests and challenge tests have been demonstrated 2
  • Urticarial skin reactions - immediate contact reactions are possible 2
  • Respiratory sensitization - trypsin and chymotrypsin are confirmed inhalable sensitizers 2

The immunological mechanism has been well-established through positive specific IgE antibodies and clinical symptoms that correlate with testing. 2 However, there is no clear evidence of delayed eczematous skin reactions from these enzymes. 2

Special Populations

Pregnancy and breastfeeding: Women who are pregnant or breastfeeding should consult a physician before using trypsin-chymotrypsin. 1

Context: Inhibitor-Related Toxicity

When trypsin and chymotrypsin inhibitors (such as aprotinin) are used in clinical settings, more serious adverse effects have been documented, including anaphylaxis (1:200 first-time use), acute renal failure, myocardial infarction, stroke, and encephalopathy. 3 However, these risks apply to the protease inhibitor aprotinin, not to the enzymes themselves when used therapeutically.

Clinical Safety Profile

The enzyme combination has been used clinically since the 1960s with an established safety record for tissue repair and anti-inflammatory applications. 4 The preparation has demonstrated antioxidant properties and reduced tissue destruction in burn injuries without significant toxicity. 5

References

Research

[Occupational Allergies to Trypsin and Chymotrypsin].

Pneumologie (Stuttgart, Germany), 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The efficacy of trypsin: chymotrypsin preparation in the reduction of oxidative damage during burn injury.

Burns : journal of the International Society for Burn Injuries, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.